ImmunoGen (Phase II Asset) is Buildings and Property in United States that focus on Drug manufacturing rights business. They cover business area such as drug manufacturing right, fro treatment, cancer, patient, b-cell malignancy, non-hodgkin lymphoma, NHL.
-
Drug Manufacturing Rights
-
830 Winter Street
Waltham, MA 02451
United States
Private
drug manufacturing rightfro treatmentcancerpatientb-cell malignancynon-hodgkin lymphomaNHL
* We use standard office opening hours in near ImmunoGen (Phase II Asset)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ImmunoGen (Phase II Asset) is Buildings and Property business from United States that founded in - ( years old in ), ImmunoGen (Phase II Asset) business is focusing on Drug Manufacturing Rights.
ImmunoGen (Phase II Asset) headquarter office and corporate office address is located in 830 Winter Street Waltham, MA 02451 United States.
ImmunoGen (Phase II Asset) was founded in United States.
In , ImmunoGen (Phase II Asset) is currently focus on Drug manufacturing rights sector.
Above is snippet of Google Trends for "Drug manufacturing rights" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ImmunoGen (Phase II Asset), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
